Trial intelligence / Profile preview

Levocetirizine vs Cetirizine Anti-H1 Potency Comparison

NCT00150761Phase 4Completed

Sponsor
UCB
Start
Jul 2004
Primary completion
Oct 2004
Modality
Small Molecules
01

Overview

A Phase 4 trial of levocetirizine in allergic rhinitis (AR), sponsored by UCB. Started Jul 2004; status: completed.

02

Drugs

levocetirizine
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NCT00150761.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00150761.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call